AVROBIO, Inc. (AVRO)
(Delayed Data from NSDQ)
$19.01 USD
+0.48 (2.59%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.01 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Tectonic Therapeutic, Inc. [AVRO]
Reports for Purchase
Showing records 21 - 40 ( 114 total )
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
ASGCT 2022 Abstract Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
AVRO Scores a Touchdown in Cystinosis at WORLDSymposium
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Fabry Takes the Backseat But Remaining Pipeline Still Cheap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Fabry Pivotal Lined Up Like Planes on the Runway
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Safety Data Should Hold The Fort Until WORLDSymposium
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department